Drug target identification is the first step in drug development, and its importance is underscored by the fact that, even when using genetic evidence to improve success rates, only a small fraction of lead targets end up approved for use in the clinic. One of the reasons for this is the lack of in-depth understanding of the complexity of human diseases.In this review we argue that network-based approaches, which are able to capture relationships between relevant genes and proteins, and diverse data modalities have high potential for improving drug target identification and drug repurposing. We present the evolution of network-based methods that have been developed for this purpose and discuss the limitations of these approaches that are holding them back from making an impact in the clinic. We finish by presenting our recommendations for overcoming these limitations, for example, by leveraging emerging technologies such as artificial intelligence and knowledge graphs.
Read full abstract- All Solutions
Editage
One platform for all researcher needs
Paperpal
AI-powered academic writing assistant
R Discovery
Your #1 AI companion for literature search
Mind the Graph
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus - Support
Overview
1276 Articles
Published in last 50 years
Related Topics
Articles published on Improve Success Rates
Authors
Select Authors
Journals
Select Journals
Duration
Select Duration
1116 Search results
Sort by Recency